Scientists at the 2026 ACTRIMS forum meet to assess current approaches and explore new directions for MS research and care.

Researchers developed a mouse model of multiple sclerosis that captures the features of progression independent of relapse ...

For decades, multiple sclerosis (MS) has been defined primarily by its symptoms, rather than its underlying biology. Now, a ...

New research suggests that Epstein-Barr virus may actively provoke the immune system in people with multiple sclerosis. Scientists found large buildups of virus-targeting immune cells in the nervous ...

Biogen swung to a loss as results were hurt by a double-digit decline in revenue from its core multiple sclerosis treatments.

Since taking over as CEO of the Cambridge biotech more than three years ago, Chris Viehbacher has cut hundreds of jobs and reduced expenses, in part by removing drugs from its research pipeline.

The results reinforce the need for individualized, biology-driven therapeutic decisions in patients with MS. SAN DIEGO – ...

A collaborative team of researchers and students from Wayne State University’s Eugene Applebaum College of Pharmacy and Health Sciences, School of Medicine, College of Liberal Arts and Sciences and ...

After being told she had just three years to live, a Sunshine Coast woman has defied the odds and reclaimed her life with the ...

Specialists in multiple sclerosis will gather in San Diego for ACTRIMS Forum 2026, Feb. 5-7, where the theme will be “MS at a ...

Advancements in MS include promising therapies like BTK inhibitors and myelin repair, evolving biomarkers, and a focus on cognition, signaling a promising future in precision medicine.

Landmark $2M detransitioner lawsuit and new guidelines raise concerns over adolescent gender-transition surgeries in the US ...